EGFL7 promotes immune evasion in glioblastoma by interaction with integrin β2
Sukrit Mahajan, Philipp Abe, Fanny Ehret…·Mirko H. H. Schmidt
This study identifies EGFL7 as a driver of immune evasion in glioblastoma by interacting with integrin β2, showing that targeting this axis enhances immunotherapy efficacy.